

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | estrogen biosynthetic process (GO:0006703) | 5.00315867 |
| 2 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.82308196 |
| 3 | protein neddylation (GO:0045116) | 4.72859777 |
| 4 | positive regulation of growth hormone secretion (GO:0060124) | 4.71001031 |
| 5 | opioid receptor signaling pathway (GO:0038003) | 4.54574092 |
| 6 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 4.54492175 |
| 7 | transmission of nerve impulse (GO:0019226) | 4.44734183 |
| 8 | behavioral response to ethanol (GO:0048149) | 4.44444680 |
| 9 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.34405404 |
| 10 | behavioral response to nicotine (GO:0035095) | 4.33400795 |
| 11 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.30632117 |
| 12 | ATP synthesis coupled proton transport (GO:0015986) | 4.21433298 |
| 13 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.21433298 |
| 14 | head development (GO:0060322) | 4.14800538 |
| 15 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.13716178 |
| 16 | negative regulation of organelle assembly (GO:1902116) | 4.10913538 |
| 17 | myoblast migration (GO:0051451) | 4.07399475 |
| 18 | forebrain neuron differentiation (GO:0021879) | 4.03451236 |
| 19 | growth hormone secretion (GO:0030252) | 4.02321461 |
| 20 | axoneme assembly (GO:0035082) | 4.01356838 |
| 21 | DNA deamination (GO:0045006) | 3.97316839 |
| 22 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.93905027 |
| 23 | ribosomal small subunit assembly (GO:0000028) | 3.92610285 |
| 24 | actin nucleation (GO:0045010) | 3.92074144 |
| 25 | cytidine metabolic process (GO:0046087) | 3.86590640 |
| 26 | cytidine catabolic process (GO:0006216) | 3.86590640 |
| 27 | cytidine deamination (GO:0009972) | 3.86590640 |
| 28 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.75523402 |
| 29 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.58931692 |
| 30 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.54929695 |
| 31 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.54468360 |
| 32 | ribosomal small subunit biogenesis (GO:0042274) | 3.51630493 |
| 33 | DNA demethylation (GO:0080111) | 3.44274874 |
| 34 | spinal cord association neuron differentiation (GO:0021527) | 3.42893305 |
| 35 | deoxyribonucleotide catabolic process (GO:0009264) | 3.41273027 |
| 36 | negative regulation of mast cell activation (GO:0033004) | 3.40524788 |
| 37 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.40396941 |
| 38 | respiratory electron transport chain (GO:0022904) | 3.37588196 |
| 39 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 3.33521090 |
| 40 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.32055788 |
| 41 | electron transport chain (GO:0022900) | 3.31848357 |
| 42 | oxidative demethylation (GO:0070989) | 3.23995136 |
| 43 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.22283508 |
| 44 | ncRNA 3-end processing (GO:0043628) | 3.19388592 |
| 45 | adaptation of signaling pathway (GO:0023058) | 3.16282390 |
| 46 | somite development (GO:0061053) | 3.12963208 |
| 47 | neurofilament cytoskeleton organization (GO:0060052) | 3.12185209 |
| 48 | gonadal mesoderm development (GO:0007506) | 3.07746132 |
| 49 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.05526330 |
| 50 | deoxyribose phosphate catabolic process (GO:0046386) | 3.04351769 |
| 51 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.03266953 |
| 52 | regulation of G0 to G1 transition (GO:0070316) | 2.98402075 |
| 53 | blood vessel maturation (GO:0001955) | 2.97233587 |
| 54 | establishment of mitochondrion localization (GO:0051654) | 2.97077443 |
| 55 | maturation of SSU-rRNA (GO:0030490) | 2.94271935 |
| 56 | sequestering of actin monomers (GO:0042989) | 2.93848796 |
| 57 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 2.93727360 |
| 58 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.93113781 |
| 59 | dendritic spine morphogenesis (GO:0060997) | 2.92436825 |
| 60 | DNA dealkylation (GO:0035510) | 2.89803470 |
| 61 | regulation of action potential (GO:0098900) | 2.88993947 |
| 62 | regulation of synapse structural plasticity (GO:0051823) | 2.85950187 |
| 63 | ubiquinone biosynthetic process (GO:0006744) | 2.85065953 |
| 64 | olfactory bulb development (GO:0021772) | 2.83959043 |
| 65 | synaptic transmission, cholinergic (GO:0007271) | 2.77342156 |
| 66 | regulation of growth hormone secretion (GO:0060123) | 2.74619351 |
| 67 | adult feeding behavior (GO:0008343) | 2.73091004 |
| 68 | GPI anchor metabolic process (GO:0006505) | 2.72918831 |
| 69 | mitochondrion transport along microtubule (GO:0047497) | 2.72474978 |
| 70 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.72474978 |
| 71 | nucleobase catabolic process (GO:0046113) | 2.72162870 |
| 72 | ubiquinone metabolic process (GO:0006743) | 2.72095228 |
| 73 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.71761728 |
| 74 | viral transcription (GO:0019083) | 2.71672918 |
| 75 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.69551932 |
| 76 | pyrimidine-containing compound catabolic process (GO:0072529) | 2.68787409 |
| 77 | translational termination (GO:0006415) | 2.67030712 |
| 78 | cellular ketone body metabolic process (GO:0046950) | 2.66612421 |
| 79 | forebrain morphogenesis (GO:0048853) | 2.65120910 |
| 80 | negative regulation of telomere maintenance (GO:0032205) | 2.65072573 |
| 81 | layer formation in cerebral cortex (GO:0021819) | 2.64694144 |
| 82 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.62794865 |
| 83 | DNA damage response, detection of DNA damage (GO:0042769) | 2.62295961 |
| 84 | monocyte chemotaxis (GO:0002548) | 2.59829297 |
| 85 | negative regulation of interleukin-1 production (GO:0032692) | 2.58741031 |
| 86 | protein complex biogenesis (GO:0070271) | 2.58521753 |
| 87 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.58203083 |
| 88 | brain morphogenesis (GO:0048854) | 2.57319295 |
| 89 | glomerulus development (GO:0032835) | 2.56483929 |
| 90 | sulfate transport (GO:0008272) | 2.55984613 |
| 91 | proteasome assembly (GO:0043248) | 2.52643714 |
| 92 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.52147220 |
| 93 | nucleoside diphosphate catabolic process (GO:0009134) | 2.52141712 |
| 94 | cell proliferation in forebrain (GO:0021846) | 2.48645906 |
| 95 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.48630130 |
| 96 | regulation of response to food (GO:0032095) | 2.47322156 |
| 97 | hydrogen ion transmembrane transport (GO:1902600) | 2.45173600 |
| 98 | thalamus development (GO:0021794) | 2.43893114 |
| 99 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.42400073 |
| 100 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.41363643 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.44665537 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.31053362 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.73313613 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.63286339 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.56159201 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 2.39330664 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.39036141 |
| 8 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.24630207 |
| 9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.19048730 |
| 10 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.04721837 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.99288042 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.97618747 |
| 13 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.91721415 |
| 14 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.90902632 |
| 15 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.88909056 |
| 16 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.86269891 |
| 17 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.83858812 |
| 18 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.73555953 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.71597811 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.65982496 |
| 21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.63660852 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.62124449 |
| 23 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.60560522 |
| 24 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.57069454 |
| 25 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.57033000 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.56732460 |
| 27 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.55941111 |
| 28 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.52832054 |
| 29 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.51518111 |
| 30 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.50977554 |
| 31 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.49670055 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.49089453 |
| 33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.48116483 |
| 34 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.44868266 |
| 35 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.44780228 |
| 36 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.44716269 |
| 37 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.41105633 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.38722091 |
| 39 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.37149217 |
| 40 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.36664171 |
| 41 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36591438 |
| 42 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.36041756 |
| 43 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.29729009 |
| 44 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.29729009 |
| 45 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.29419073 |
| 46 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.28914354 |
| 47 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.26854192 |
| 48 | EWS_26573619_Chip-Seq_HEK293_Human | 1.26725231 |
| 49 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.26279782 |
| 50 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24989917 |
| 51 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.24171132 |
| 52 | NCOR_22424771_ChIP-Seq_293T_Human | 1.23621555 |
| 53 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.22254287 |
| 54 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.22100257 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.21998308 |
| 56 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.21733912 |
| 57 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.21347495 |
| 58 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.20399279 |
| 59 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.20076974 |
| 60 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.19830930 |
| 61 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.16698980 |
| 62 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.16100996 |
| 63 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.15295502 |
| 64 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.13952462 |
| 65 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.12550296 |
| 66 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.11903061 |
| 67 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.11355611 |
| 68 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.11205565 |
| 69 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.10429334 |
| 70 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.09865537 |
| 71 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.07205648 |
| 72 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.06288265 |
| 73 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.04673157 |
| 74 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03522082 |
| 75 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03479802 |
| 76 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.02677654 |
| 77 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.01302243 |
| 78 | ERA_21632823_ChIP-Seq_H3396_Human | 1.00014651 |
| 79 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.99833469 |
| 80 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.99066627 |
| 81 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.99066627 |
| 82 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.98964391 |
| 83 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.98828160 |
| 84 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.97987543 |
| 85 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.97771354 |
| 86 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.97764600 |
| 87 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.97030752 |
| 88 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.96872572 |
| 89 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.96774551 |
| 90 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.95983575 |
| 91 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.95860912 |
| 92 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.95508964 |
| 93 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.94269020 |
| 94 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.94218733 |
| 95 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.93963544 |
| 96 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.93415462 |
| 97 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.92930167 |
| 98 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.92921149 |
| 99 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.92598392 |
| 100 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.92471811 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002102_abnormal_ear_morphology | 4.37687866 |
| 2 | MP0003122_maternal_imprinting | 3.87572070 |
| 3 | MP0003787_abnormal_imprinting | 3.78879683 |
| 4 | MP0004145_abnormal_muscle_electrophysio | 3.43781087 |
| 5 | MP0006292_abnormal_olfactory_placode | 3.03252859 |
| 6 | MP0009379_abnormal_foot_pigmentation | 3.01292451 |
| 7 | MP0006276_abnormal_autonomic_nervous | 2.64980838 |
| 8 | MP0001968_abnormal_touch/_nociception | 2.59254384 |
| 9 | MP0003121_genomic_imprinting | 2.57177174 |
| 10 | MP0008877_abnormal_DNA_methylation | 2.44061203 |
| 11 | MP0003646_muscle_fatigue | 2.32994804 |
| 12 | MP0005645_abnormal_hypothalamus_physiol | 2.32786676 |
| 13 | MP0002733_abnormal_thermal_nociception | 2.19063310 |
| 14 | MP0003880_abnormal_central_pattern | 2.16524414 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.16372249 |
| 16 | MP0010386_abnormal_urinary_bladder | 2.01762226 |
| 17 | MP0004859_abnormal_synaptic_plasticity | 2.00706911 |
| 18 | MP0005423_abnormal_somatic_nervous | 2.00267896 |
| 19 | MP0001188_hyperpigmentation | 1.96414860 |
| 20 | MP0001984_abnormal_olfaction | 1.83057191 |
| 21 | MP0000778_abnormal_nervous_system | 1.80115045 |
| 22 | MP0001970_abnormal_pain_threshold | 1.75906971 |
| 23 | MP0001485_abnormal_pinna_reflex | 1.69394817 |
| 24 | MP0002063_abnormal_learning/memory/cond | 1.68334551 |
| 25 | MP0002184_abnormal_innervation | 1.66641625 |
| 26 | MP0004742_abnormal_vestibular_system | 1.60707641 |
| 27 | MP0003635_abnormal_synaptic_transmissio | 1.57180522 |
| 28 | MP0005646_abnormal_pituitary_gland | 1.55637093 |
| 29 | MP0003011_delayed_dark_adaptation | 1.53760776 |
| 30 | MP0001905_abnormal_dopamine_level | 1.53052528 |
| 31 | MP0002736_abnormal_nociception_after | 1.53035324 |
| 32 | MP0005084_abnormal_gallbladder_morpholo | 1.51314691 |
| 33 | MP0005551_abnormal_eye_electrophysiolog | 1.46956984 |
| 34 | MP0004142_abnormal_muscle_tone | 1.43907094 |
| 35 | MP0004134_abnormal_chest_morphology | 1.41052024 |
| 36 | MP0009745_abnormal_behavioral_response | 1.39684396 |
| 37 | MP0000049_abnormal_middle_ear | 1.34771521 |
| 38 | MP0001486_abnormal_startle_reflex | 1.34322379 |
| 39 | MP0004885_abnormal_endolymph | 1.33969447 |
| 40 | MP0000631_abnormal_neuroendocrine_gland | 1.31436875 |
| 41 | MP0002638_abnormal_pupillary_reflex | 1.28988413 |
| 42 | MP0005083_abnormal_biliary_tract | 1.27536441 |
| 43 | MP0002272_abnormal_nervous_system | 1.27151280 |
| 44 | MP0001764_abnormal_homeostasis | 1.25121081 |
| 45 | MP0002572_abnormal_emotion/affect_behav | 1.24182293 |
| 46 | MP0002734_abnormal_mechanical_nocicepti | 1.24175363 |
| 47 | MP0002095_abnormal_skin_pigmentation | 1.22263764 |
| 48 | MP0002837_dystrophic_cardiac_calcinosis | 1.22054733 |
| 49 | MP0008789_abnormal_olfactory_epithelium | 1.20750703 |
| 50 | MP0002557_abnormal_social/conspecific_i | 1.18990487 |
| 51 | MP0004133_heterotaxia | 1.18326498 |
| 52 | MP0003938_abnormal_ear_development | 1.18035818 |
| 53 | MP0002735_abnormal_chemical_nociception | 1.17588558 |
| 54 | MP0000955_abnormal_spinal_cord | 1.16399462 |
| 55 | MP0002752_abnormal_somatic_nervous | 1.13029795 |
| 56 | MP0008569_lethality_at_weaning | 1.10644287 |
| 57 | MP0002909_abnormal_adrenal_gland | 1.08573966 |
| 58 | MP0001293_anophthalmia | 1.07058175 |
| 59 | MP0005394_taste/olfaction_phenotype | 1.04682794 |
| 60 | MP0005499_abnormal_olfactory_system | 1.04682794 |
| 61 | MP0000026_abnormal_inner_ear | 1.04084633 |
| 62 | MP0005671_abnormal_response_to | 1.03340444 |
| 63 | MP0008875_abnormal_xenobiotic_pharmacok | 1.02497194 |
| 64 | MP0002067_abnormal_sensory_capabilities | 0.98348201 |
| 65 | MP0005253_abnormal_eye_physiology | 0.97245663 |
| 66 | MP0003137_abnormal_impulse_conducting | 0.95231790 |
| 67 | MP0002653_abnormal_ependyma_morphology | 0.95068241 |
| 68 | MP0002882_abnormal_neuron_morphology | 0.95013072 |
| 69 | MP0002938_white_spotting | 0.92545283 |
| 70 | MP0008872_abnormal_physiological_respon | 0.91605520 |
| 71 | MP0003567_abnormal_fetal_cardiomyocyte | 0.91499048 |
| 72 | MP0006072_abnormal_retinal_apoptosis | 0.90887224 |
| 73 | MP0001529_abnormal_vocalization | 0.90015651 |
| 74 | MP0004858_abnormal_nervous_system | 0.88855573 |
| 75 | MP0004270_analgesia | 0.88791211 |
| 76 | MP0002234_abnormal_pharynx_morphology | 0.86170129 |
| 77 | MP0005670_abnormal_white_adipose | 0.85480092 |
| 78 | MP0005195_abnormal_posterior_eye | 0.84894066 |
| 79 | MP0006054_spinal_hemorrhage | 0.80678784 |
| 80 | MP0002160_abnormal_reproductive_system | 0.80390402 |
| 81 | MP0005266_abnormal_metabolism | 0.80356013 |
| 82 | MP0003119_abnormal_digestive_system | 0.79770956 |
| 83 | MP0001765_abnormal_ion_homeostasis | 0.79497166 |
| 84 | MP0000230_abnormal_systemic_arterial | 0.79294843 |
| 85 | MP0000537_abnormal_urethra_morphology | 0.78640136 |
| 86 | MP0002152_abnormal_brain_morphology | 0.74463286 |
| 87 | MP0000534_abnormal_ureter_morphology | 0.72646057 |
| 88 | MP0002064_seizures | 0.72280912 |
| 89 | MP0005171_absent_coat_pigmentation | 0.71117071 |
| 90 | MP0001963_abnormal_hearing_physiology | 0.70222221 |
| 91 | MP0005389_reproductive_system_phenotype | 0.70053957 |
| 92 | MP0004130_abnormal_muscle_cell | 0.68955871 |
| 93 | MP0004811_abnormal_neuron_physiology | 0.68681211 |
| 94 | MP0002210_abnormal_sex_determination | 0.68217518 |
| 95 | MP0003878_abnormal_ear_physiology | 0.67619867 |
| 96 | MP0005377_hearing/vestibular/ear_phenot | 0.67619867 |
| 97 | MP0002090_abnormal_vision | 0.64777997 |
| 98 | MP0001286_abnormal_eye_development | 0.61249866 |
| 99 | MP0003942_abnormal_urinary_system | 0.60930491 |
| 100 | MP0005248_abnormal_Harderian_gland | 0.60909609 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stenosis of the external auditory canal (HP:0000402) | 4.44251829 |
| 2 | Abnormality of midbrain morphology (HP:0002418) | 3.64830052 |
| 3 | Molar tooth sign on MRI (HP:0002419) | 3.64830052 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 3.56517611 |
| 5 | Pancreatic cysts (HP:0001737) | 3.50801202 |
| 6 | True hermaphroditism (HP:0010459) | 3.43897519 |
| 7 | Nephronophthisis (HP:0000090) | 3.40765706 |
| 8 | Pancreatic fibrosis (HP:0100732) | 3.40443823 |
| 9 | Agitation (HP:0000713) | 3.35427440 |
| 10 | Chronic hepatic failure (HP:0100626) | 3.21031592 |
| 11 | Reticulocytopenia (HP:0001896) | 3.19383809 |
| 12 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.19324228 |
| 13 | Methylmalonic acidemia (HP:0002912) | 3.06350330 |
| 14 | Progressive macrocephaly (HP:0004481) | 3.01059418 |
| 15 | Abolished electroretinogram (ERG) (HP:0000550) | 2.99424917 |
| 16 | Severe visual impairment (HP:0001141) | 2.97862738 |
| 17 | Polyphagia (HP:0002591) | 2.96968654 |
| 18 | Mitochondrial inheritance (HP:0001427) | 2.87352192 |
| 19 | Pendular nystagmus (HP:0012043) | 2.83831325 |
| 20 | Acute encephalopathy (HP:0006846) | 2.83476817 |
| 21 | Type 2 muscle fiber atrophy (HP:0003554) | 2.78233520 |
| 22 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.72305642 |
| 23 | Abnormality of alanine metabolism (HP:0010916) | 2.71072167 |
| 24 | Hyperalaninemia (HP:0003348) | 2.71072167 |
| 25 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.71072167 |
| 26 | Cerebral edema (HP:0002181) | 2.64028764 |
| 27 | 3-Methylglutaconic aciduria (HP:0003535) | 2.63498969 |
| 28 | Oligomenorrhea (HP:0000876) | 2.60692700 |
| 29 | Cortical dysplasia (HP:0002539) | 2.57783481 |
| 30 | Renal Fanconi syndrome (HP:0001994) | 2.54459805 |
| 31 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.53698316 |
| 32 | Abnormality of the renal medulla (HP:0100957) | 2.51923247 |
| 33 | Abnormality of urine glucose concentration (HP:0011016) | 2.46460461 |
| 34 | Glycosuria (HP:0003076) | 2.46460461 |
| 35 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.45941621 |
| 36 | Abnormality of homocysteine metabolism (HP:0010919) | 2.45861045 |
| 37 | Homocystinuria (HP:0002156) | 2.45861045 |
| 38 | Increased CSF lactate (HP:0002490) | 2.45729801 |
| 39 | Medial flaring of the eyebrow (HP:0010747) | 2.45450131 |
| 40 | Abnormality of the renal cortex (HP:0011035) | 2.41028753 |
| 41 | Increased hepatocellular lipid droplets (HP:0006565) | 2.38238165 |
| 42 | Generalized aminoaciduria (HP:0002909) | 2.37648591 |
| 43 | Abnormality of the labia minora (HP:0012880) | 2.35751169 |
| 44 | Gonadotropin excess (HP:0000837) | 2.35446011 |
| 45 | Cystic liver disease (HP:0006706) | 2.35002241 |
| 46 | Increased intramyocellular lipid droplets (HP:0012240) | 2.31454391 |
| 47 | Methylmalonic aciduria (HP:0012120) | 2.31035970 |
| 48 | Bifid tongue (HP:0010297) | 2.30029521 |
| 49 | Aplastic anemia (HP:0001915) | 2.29482884 |
| 50 | Megalencephaly (HP:0001355) | 2.26789560 |
| 51 | Morphological abnormality of the middle ear (HP:0008609) | 2.26693397 |
| 52 | Muscle fiber atrophy (HP:0100295) | 2.23068725 |
| 53 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.20014331 |
| 54 | Abnormality of renal resorption (HP:0011038) | 2.17727367 |
| 55 | IgG deficiency (HP:0004315) | 2.15427639 |
| 56 | Congenital stationary night blindness (HP:0007642) | 2.13819127 |
| 57 | Abnormal lung lobation (HP:0002101) | 2.11236133 |
| 58 | Sclerocornea (HP:0000647) | 2.09922218 |
| 59 | Palpebral edema (HP:0100540) | 2.08508043 |
| 60 | Hepatic necrosis (HP:0002605) | 2.08455289 |
| 61 | Lipid accumulation in hepatocytes (HP:0006561) | 2.06726561 |
| 62 | Abnormality of macular pigmentation (HP:0008002) | 2.06562911 |
| 63 | Sleep apnea (HP:0010535) | 2.05848638 |
| 64 | Cerebral hypomyelination (HP:0006808) | 2.03929284 |
| 65 | Keratoconus (HP:0000563) | 2.01700848 |
| 66 | Increased corneal curvature (HP:0100692) | 2.01700848 |
| 67 | Optic disc pallor (HP:0000543) | 2.00976616 |
| 68 | Drooling (HP:0002307) | 1.97205880 |
| 69 | Renal cortical cysts (HP:0000803) | 1.96290900 |
| 70 | Leukodystrophy (HP:0002415) | 1.96072162 |
| 71 | Hepatocellular necrosis (HP:0001404) | 1.95510268 |
| 72 | Myokymia (HP:0002411) | 1.95144161 |
| 73 | Hyperphosphaturia (HP:0003109) | 1.93769348 |
| 74 | Congenital hepatic fibrosis (HP:0002612) | 1.93677198 |
| 75 | Abnormal pancreas size (HP:0012094) | 1.92805817 |
| 76 | Poor suck (HP:0002033) | 1.92770489 |
| 77 | Anencephaly (HP:0002323) | 1.92523461 |
| 78 | Narrow forehead (HP:0000341) | 1.91637848 |
| 79 | Lethargy (HP:0001254) | 1.90298035 |
| 80 | Abnormal number of erythroid precursors (HP:0012131) | 1.90259789 |
| 81 | Abnormal eating behavior (HP:0100738) | 1.89969157 |
| 82 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.89890193 |
| 83 | Postaxial hand polydactyly (HP:0001162) | 1.89519158 |
| 84 | Absent thumb (HP:0009777) | 1.88969784 |
| 85 | Male pseudohermaphroditism (HP:0000037) | 1.88127791 |
| 86 | Failure to thrive in infancy (HP:0001531) | 1.86076755 |
| 87 | Postaxial foot polydactyly (HP:0001830) | 1.82557604 |
| 88 | Focal seizures (HP:0007359) | 1.80978065 |
| 89 | Abnormal drinking behavior (HP:0030082) | 1.79117984 |
| 90 | Polydipsia (HP:0001959) | 1.79117984 |
| 91 | Excessive salivation (HP:0003781) | 1.78675990 |
| 92 | B lymphocytopenia (HP:0010976) | 1.78186116 |
| 93 | Increased muscle lipid content (HP:0009058) | 1.78004713 |
| 94 | Pachygyria (HP:0001302) | 1.76701055 |
| 95 | Acute hepatic failure (HP:0006554) | 1.76526465 |
| 96 | Tubular atrophy (HP:0000092) | 1.75080963 |
| 97 | Abnormal urine phosphate concentration (HP:0012599) | 1.74498412 |
| 98 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.74435718 |
| 99 | Anophthalmia (HP:0000528) | 1.74144308 |
| 100 | Absent eyebrow (HP:0002223) | 1.69821188 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.56427683 |
| 2 | CDK19 | 3.73749229 |
| 3 | ADRBK2 | 3.52411977 |
| 4 | WNK3 | 2.86930759 |
| 5 | PINK1 | 2.84890216 |
| 6 | WNK4 | 2.59051156 |
| 7 | GRK1 | 2.55131858 |
| 8 | MAP2K7 | 2.44761392 |
| 9 | BMPR1B | 2.40728416 |
| 10 | PDK2 | 2.34566850 |
| 11 | MAP3K12 | 2.29572173 |
| 12 | NTRK2 | 2.25411936 |
| 13 | NEK1 | 2.17742484 |
| 14 | MUSK | 2.13957384 |
| 15 | MAP3K4 | 2.12095836 |
| 16 | DYRK2 | 2.09608014 |
| 17 | FRK | 2.05307004 |
| 18 | TESK2 | 2.03882541 |
| 19 | TNK2 | 1.94826571 |
| 20 | VRK2 | 1.79289867 |
| 21 | KDR | 1.75568176 |
| 22 | TXK | 1.72251044 |
| 23 | PAK3 | 1.50840931 |
| 24 | TAOK2 | 1.45833425 |
| 25 | PRKCG | 1.34604988 |
| 26 | LIMK1 | 1.33791236 |
| 27 | MINK1 | 1.30252968 |
| 28 | PAK6 | 1.25833300 |
| 29 | MARK1 | 1.20747619 |
| 30 | SIK2 | 1.14847453 |
| 31 | ERBB3 | 1.08404984 |
| 32 | RPS6KA4 | 1.07130139 |
| 33 | MAPK13 | 0.98405164 |
| 34 | NUAK1 | 0.94980367 |
| 35 | BUB1 | 0.93241507 |
| 36 | EPHB2 | 0.89921932 |
| 37 | NTRK3 | 0.89396259 |
| 38 | STK39 | 0.89114490 |
| 39 | DAPK1 | 0.89051226 |
| 40 | CSNK1G3 | 0.87388369 |
| 41 | MAPKAPK3 | 0.86349885 |
| 42 | PRKCQ | 0.83339958 |
| 43 | CAMKK2 | 0.81009102 |
| 44 | NEK2 | 0.80518941 |
| 45 | SGK494 | 0.78542983 |
| 46 | SGK223 | 0.78542983 |
| 47 | MAP4K2 | 0.77696127 |
| 48 | FES | 0.74419585 |
| 49 | CSNK1G1 | 0.71145552 |
| 50 | ADRBK1 | 0.71052302 |
| 51 | BRSK1 | 0.70293777 |
| 52 | CSNK1G2 | 0.70149279 |
| 53 | NTRK1 | 0.69118076 |
| 54 | TRIM28 | 0.69032078 |
| 55 | MYLK | 0.68658451 |
| 56 | INSRR | 0.64909261 |
| 57 | CAMK1 | 0.64616737 |
| 58 | TNIK | 0.62697093 |
| 59 | AKT3 | 0.62251401 |
| 60 | VRK1 | 0.62214062 |
| 61 | ITK | 0.61777605 |
| 62 | CAMK2A | 0.59382381 |
| 63 | PRKD3 | 0.58808096 |
| 64 | PIK3CA | 0.58565380 |
| 65 | CSNK1A1 | 0.49552036 |
| 66 | TIE1 | 0.49539815 |
| 67 | OBSCN | 0.47794001 |
| 68 | ILK | 0.46526194 |
| 69 | TESK1 | 0.46104114 |
| 70 | ERBB2 | 0.44684175 |
| 71 | PLK1 | 0.44374574 |
| 72 | CSNK1A1L | 0.43732861 |
| 73 | WEE1 | 0.43500947 |
| 74 | PRKACA | 0.43130617 |
| 75 | CSNK2A1 | 0.41546108 |
| 76 | OXSR1 | 0.41389396 |
| 77 | CDK5 | 0.40241462 |
| 78 | PLK2 | 0.38688871 |
| 79 | PNCK | 0.37035028 |
| 80 | MAP3K11 | 0.36264713 |
| 81 | TYRO3 | 0.35915810 |
| 82 | CSNK2A2 | 0.35678707 |
| 83 | PRKCH | 0.35626219 |
| 84 | AURKA | 0.35485874 |
| 85 | PRKCA | 0.34618763 |
| 86 | MAPK15 | 0.34613410 |
| 87 | CDK11A | 0.34609424 |
| 88 | MAP2K4 | 0.33094544 |
| 89 | FYN | 0.31581877 |
| 90 | PRKCE | 0.30638498 |
| 91 | PAK1 | 0.30094139 |
| 92 | SGK2 | 0.29028912 |
| 93 | DYRK1B | 0.27696961 |
| 94 | SYK | 0.27660477 |
| 95 | LCK | 0.26925325 |
| 96 | PRKCB | 0.26836109 |
| 97 | RPS6KB1 | 0.26464994 |
| 98 | PRKACB | 0.26396163 |
| 99 | INSR | 0.25289191 |
| 100 | PRPF4B | 0.25139127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.07677479 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 3.37925243 |
| 3 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.02379021 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.02064562 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 2.99144468 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.74800536 |
| 7 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.73414859 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.68597807 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.53306545 |
| 10 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.52360579 |
| 11 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.47919219 |
| 12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.39153446 |
| 13 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.22385081 |
| 14 | Huntingtons disease_Homo sapiens_hsa05016 | 2.20462673 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.14789199 |
| 16 | Protein export_Homo sapiens_hsa03060 | 1.86458132 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 1.85624774 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.84347278 |
| 19 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.64660281 |
| 20 | Nicotine addiction_Homo sapiens_hsa05033 | 1.62730153 |
| 21 | Phototransduction_Homo sapiens_hsa04744 | 1.59184497 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.57960355 |
| 23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.55700144 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.46610728 |
| 25 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.44758847 |
| 26 | Proteasome_Homo sapiens_hsa03050 | 1.41818293 |
| 27 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.37031121 |
| 28 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.31619200 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.30816987 |
| 30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.27403575 |
| 31 | Homologous recombination_Homo sapiens_hsa03440 | 1.22697073 |
| 32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.17596008 |
| 33 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.08339178 |
| 34 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.03202295 |
| 35 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.96408339 |
| 36 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.94620669 |
| 37 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.92928629 |
| 38 | GABAergic synapse_Homo sapiens_hsa04727 | 0.91163202 |
| 39 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.87665610 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.86820949 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.84418656 |
| 42 | Morphine addiction_Homo sapiens_hsa05032 | 0.82945928 |
| 43 | Olfactory transduction_Homo sapiens_hsa04740 | 0.82385287 |
| 44 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.81886309 |
| 45 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.81475066 |
| 46 | RNA polymerase_Homo sapiens_hsa03020 | 0.79645543 |
| 47 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.78751764 |
| 48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.78569524 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.78419144 |
| 50 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.77757643 |
| 51 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.74667673 |
| 52 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.70937027 |
| 53 | Retinol metabolism_Homo sapiens_hsa00830 | 0.70175007 |
| 54 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.69493692 |
| 55 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.69435014 |
| 56 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.69424202 |
| 57 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.66997221 |
| 58 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.64931327 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 0.64690364 |
| 60 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.64123283 |
| 61 | Metabolic pathways_Homo sapiens_hsa01100 | 0.60991731 |
| 62 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58577013 |
| 63 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.54671128 |
| 64 | Insulin secretion_Homo sapiens_hsa04911 | 0.52378901 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 0.51457931 |
| 66 | Basal transcription factors_Homo sapiens_hsa03022 | 0.51312382 |
| 67 | Axon guidance_Homo sapiens_hsa04360 | 0.50918337 |
| 68 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.50121112 |
| 69 | Cocaine addiction_Homo sapiens_hsa05030 | 0.49968182 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.49326438 |
| 71 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.48513021 |
| 72 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.47253117 |
| 73 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.46525433 |
| 74 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.45566461 |
| 75 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.45014780 |
| 76 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.42811655 |
| 77 | Purine metabolism_Homo sapiens_hsa00230 | 0.41811290 |
| 78 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.41326611 |
| 79 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.40634318 |
| 80 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.39574819 |
| 81 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.39458715 |
| 82 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.39075633 |
| 83 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.38902038 |
| 84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.38819562 |
| 85 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38600035 |
| 86 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.37565815 |
| 87 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.37193994 |
| 88 | Circadian entrainment_Homo sapiens_hsa04713 | 0.36909140 |
| 89 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.36784020 |
| 90 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.36724600 |
| 91 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.36108742 |
| 92 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.35860462 |
| 93 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.34790020 |
| 94 | Melanoma_Homo sapiens_hsa05218 | 0.33255443 |
| 95 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.30779719 |
| 96 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.29535129 |
| 97 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.28879087 |
| 98 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.28864152 |
| 99 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.27748391 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.27122645 |

